PROVIDER PROFILE · NPI 1629367602

Patrick OgidanM.D.

PRACTICEWOODLANDS DIAGNOSTIC CLINIC, PASee all providers at this practice →

Internal MedicineShenandoah, TXI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

614

Unique beneficiaries

—

Total services

2,180

Distinct HCPCS

Medicare payment

$83K

Peer benchmark

Total Medicare services vs. 6,183 Internal Medicine providers in TX — top quintile (cohort median 673).

PRESCRIBING · PART D · 2024

Total Rx claims

9,557

Beneficiaries

—

Total drug cost

$814K

Distinct drugs

168

Brand share

20.7%

Top prescribed drugs

Levothyroxine Sodium547 claims

Atorvastatin Calcium426 claims

Pantoprazole Sodium292 claims

Amlodipine Besylate260 claims

Gabapentin198 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$772

Payment records

By payment type

Food and Beverage$772

REFERRAL NETWORK

Where Patrick Ogidan's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 6 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Quest Diagnostics Clinical Laboratories Inc Clinical Laboratory · Houston, TX	84	277
COLEMAN, KRISTIN	73	229
Rachel Koster Physician Assistant · Chubbuck, ID	30	65
Amie Sun-Wright Internal Medicine · Spring, TX	22	61
TOPS SPECIALTY HOSPITAL, LTD.	21	37
Afua Agyarko Internal Medicine · Spring, TX	16	64

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history